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ABSTRACT
CAUSALITY ANALYSIS IN BIOLOGICAL NETWORKS
O¨zgu¨n Babur
Ph.D. in Computer Engineering
Supervisor: Assoc. Prof. Dr. Ug˘ur Dog˘ruso¨z
January, 2010
Systems biology is a rapidly emerging field, shaped in the last two decades
or so, which promises understanding and curing several complex diseases such as
cancer. In order to get an insight about the system – specifically the molecular
network in the cell – we need to work on following four fundamental aspects:
experimental and computational methods to gather knowledge about the system,
mathematical models for representing the knowledge, analysis methods for an-
swering questions on the model, and software tools for working on these. In this
thesis, we propose new approaches related to all these aspects.
In this thesis, we define new terms and concepts that helps us to analyze
cellular processes, such as positive and negative paths, upstream and downstream
relations, and distance in process graphs. We propose algorithms that will search
for functional relations between molecules and will answer several biologically
interesting questions related to the network, such as neighborhoods, paths of
interest, and common targets or regulators of molecules.
In addition, we introduce ChiBE, a pathway editor for visualizing and ana-
lyzing BioPAX networks. The tool converts BioPAX graphs to drawable process
diagrams and provides the mentioned novel analysis algorithms. Users can query
pathways in Pathway Commons database and create sub-networks that focus on
specific relations of interest.
We also describe a microarray data analysis component, PATIKAmad, built
into ChiBE and PATIKAweb, which integrates expression experiment data with
networks. PATIKAmad helps those tools to represent experiment values on net-
work elements and to search for causal relations in the network that potentially
explain dependent expressions. Causative path search depends on the presence of
transcriptional relations in the model, which however is underrepresented in most
iv
vof the databases. This is mainly due to insufficient knowledge in the literature.
We finally propose a method for identifying and classifying modulators of
transcription factors, to help complete the missing transcriptional relations in
the pathway databases. The method works with large amount of expression
data, and looks for evidence of modulation for triplets of genes, i.e. modulator -
factor - target. Modulator candidates are chosen among the interacting proteins
of transcription factors. We expect to observe that expression of the target gene
depends on the interaction between factor and modulator. According to the ob-
served dependency type, we further classify the modulation. When tested, our
method finds modulators of Androgen Receptor; our top-scoring result modula-
tors are supported by other evidence in the literature. We also observe that the
modulation event and modulation type highly depend on the specific target gene.
This finding contradicts with expectations of molecular biology community who
often assume a modulator has one type of effect regardless of the target gene.
Keywords: Computational biology, bioinformatics, systems biology, pathway in-
formatics, causality analysis.
O¨ZET
BI˙YOLOJI˙K AG˘LARDA NEDENSELLI˙K ANALI˙ZI˙
O¨zgu¨n Babur
Bilgisayar Mu¨hendislig˘i, Doktora
Tez Yo¨neticisi: Doc¸ent Dr. Ug˘ur Dog˘ruso¨z
Ocak, 2010
Sistem biyolojisi son birkac¸ on yılda s¸ekillenmis¸, ve kanser gibi karmas¸ık
hastalıklara c¸o¨zu¨m vadeden bir alandır. Sistem hakkında (daha spesifik olarak
hu¨cresel ag˘lar hakkında) bir kavrayıs¸ gelis¸tirebilmek ic¸in s¸u do¨rt temel alanda
calıs¸malar yapmak gerekir: sistem hakkında bilgi toplamak ic¸in deneysel ve hesap-
sal metotlar, bilgiyi go¨stermek ic¸in matematiksel modeller, model hakkındaki
sorulara cevap bulan analiz yo¨ntemleri, ve bu¨tu¨n bunlar u¨zerinde c¸alıs¸mamıza
yardımcı olacak yazılım arac¸ları. Bu tezde, bahsedilen bu¨tu¨n alanlarla ilgili yeni
yaklas¸ımlar sunuyoruz.
Bu tezde, pozitif ve negatif etkili yolaklar, akıs¸yukarı ve akıs¸as¸ag˘ı ilis¸kiler, ve
su¨rec¸ c¸izgelerinde uzaklık gibi terimler ve kavramlar tanımlıyoruz. Koms¸uluk,
ilgilenilen ag˘lar, ve ortak hedef ve ortak du¨zenleyiciler gibi biyolojik ac¸ıdan ilginc¸
sorulara cevap u¨retecek, c¸izge u¨zerinde fonksiyonel ilis¸kiler arayan algoritmalar
o¨neriyoruz.
Buna ek olarak, BioPAX c¸izgelerini go¨rselleyen ve analiz eden ChiBE isimli
yazılımı sunuyoruz. Bu yazılım, BioPAX c¸izgelerini c¸izilebilir su¨rec¸ c¸izgelerine
c¸eviriyor ve yukarıda bahsi gec¸en algoritmaları sag˘lıyor. ChiBE kullanıcıları Path-
way Commons veritabanını sorgulayabiliyor ve kendi ilgilendikleri su¨rec¸lere odaklı
c¸izge parc¸aları u¨retebiliyorlar.
Ayrıca PATIKAmad isimli bir mikrodizi veri analiz yazılımı gelis¸tirdik, ve
mikrodizilerle biyolojik ag˘ları entegre edecek s¸ekilde ChiBE ve PATIKAweb
yazılım arac¸larında kullandık. PATIKAmad sayesinde bu arac¸lar mikrodizi
deg˘erlerini moleku¨l du¨g˘u¨mleri u¨zerinde go¨sterebiliyor ve ag˘ u¨stu¨ndeki ifadeler
arasındaki bag˘lantıları ac¸ıklama potansiyeline sahip sonuc¸sal yolakları ortaya
c¸ıkarabiliyor. Sonuc¸sal yolakların analizi, modellenen biyolojik ag˘ u¨zerinde
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yazılım ilis¸kilerinin de modellenmis¸ olmasına dayanır. Fakat yazılım ilis¸kileri biy-
olojik ag˘ veritabanlarında olması gerekenin c¸ok altında bulunmaktadır. Bunun
temel nedeni literatu¨rde bu konuda go¨rece daha az bilgi bulunmasıdır.
Son olarak, veritabanlarındaki eksik yazılım bilgisini tamamlama potansiye-
line sahip, yazılım fakto¨rlerinin modu¨lato¨rlerini tahmin eden ve sınıflayan bir
yo¨ntem o¨neriyoruz. Bu yo¨ntem c¸ok sayıda mikrodizi verisini kullanarak modu-
lato¨r - fakto¨r - hedef gen u¨c¸lu¨leri arasında modu¨lasyon ilis¸kisi arıyor. Modulato¨r
adaylarını yazılım fakto¨ru¨nu¨n etkiles¸tig˘i bilinen proteinler arasından sec¸iyoruz ve
hedef genin ifadesinin fakto¨r ve modu¨lato¨r arasındaki etkiles¸imden etkilenmesini
bekliyoruz. Go¨zlenen etki s¸ekline go¨re modu¨lato¨rleri ayrıca sınıflandırıyoruz.
Metodumuzu Androjen Resepto¨ru¨ u¨zerinde denedig˘imiz zaman go¨ru¨yoruz ki
yu¨ksek puanlı modu¨lato¨rler literatu¨rdeki bas¸ka kanıtlarla da destekleniyor.
Bu aras¸tırmada go¨zledig˘imiz dig˘er bir olgu ise modu¨lato¨rlerin etkisinin ve
sınıfının c¸og˘unlukla hedef gene go¨re farklılık go¨stermesidir. Halbuki literatu¨rdeki
c¸alıs¸malar modu¨lato¨rleri genellikle hedef genden bag˘ımsız tek tip etkiye go¨re (ak-
tifles¸tirici ve engelleyici) sınıflandırmaya c¸alıs¸ıyor.
Anahtar so¨zcu¨kler : Biyoenformatik, Nedensellik analizi.
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Chapter 1
Introduction
1.1 Biological Pathways
Events happening in the cell has always been interesting to the scientific com-
munity since most of the diseases are related to malfunctioning of a component
or interruption of normal function by external factors, like chemicals or viruses.
Modeling of these events creates pathways, which can be diverse in structure and
the encoded information. Structure of pathways is generally affected from the
viewpoint of researchers, and the experimental methods that supply information
about the event.
There are some customary types of pathways such as metabolic, protein in-
teraction, signaling, gene regulatory, and genetic interaction networks. Today
there are various efforts to integrate these different representations and create a
standard representation.
Metabolic networks focus on enzymatic reactions, specifying substrates and
products. The identity of the enzyme itself can be unknown and reactants can
be generic, i.e. representing a set of molecules that have a common chemical
property (Figure 1.1). Reactions are generally discovered with biochemical assays,
performed in a test tube (in vitro). These assays can also identify several rate
1
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Figure 1.1: Metabolic network example from KEGG database [46].
constants of the reaction. When rate constants and molecule identities are known,
it is possible to simulate metabolic pathways on computer (in silico) [65, 12].
Signaling networks are the bridges between external signals and metabolic
events. Complexity of a signaling network increases with the complexity of the
associated organism. This kind of networks capture the signal flow between the
signaling molecules (Figure 1.2). Phosphorylation and de-phosphorylation of pro-
teins constitute a great deal of signaling events, performed by kinases and phos-
photases, detected with kinase assays.
Protein interaction networks are the simplest and the most popular type.
An edge between two protein nodes indicates an interaction (Figure 1.3). High-
throughput experiments, like yeast two-hybrid assays, provide massive amounts
of protein interaction data.
Gene regulatory networks capture the relation between genes in terms of the
regulation of expression. Edges in these directed networks indicate the activity
of the source gene affecting the expression of the target gene. These networks are
generally inferred using gene expression datasets [58].
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Figure 1.2: Signaling network example from CSNDB database [74].
Figure 1.3: Protein-protein interaction network from PATIKA database [28].
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Figure 1.4: Genetic interaction network from DRYGIN database [52].
Genetic interaction networks relate genes whose interaction (probably indi-
rect) is associated with a certain phenotype (Figure 1.4). For instance, if a yeast
strain dies when genes A and B are knocked out together, but is not affected
when only one of them is knocked out, then we say there is a genetic inteaction
between genes A and B. A recent high-throughput technique called Synthetic
Genetic Array (SGA) analysis is developed for quantitatively identifying genetic
interactions based on synthetic lethality [75].
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Figure 1.5: Idea of Central Dogma of Molecular Biology, drawn by Francis
Crick [19].
1.2 Gene Expression
In 1958, Francis Crick reported in a symposium: “Once information has got
into a protein it can’t get out again” [19]. On his report, Crick draws a model
of information flow of the genetic code in the cell (Figure 1.5). This model is
recognized as the Central Dogma of molecular biology. Today, we name each
part of the flow as:
• DNA → DNA: DNA replication by DNA polymerases
• DNA → RNA: Transcription by RNA polymerases
• RNA → Protein: Translation by ribosomes
• RNA → RNA: RNA replication by RNA dependent RNA polymerases of
some viral genomes like poliovirus
• RNA → DNA: Reverse transcription by reverse transcriptase enzyme of
some viral genomes like HIV
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Second and third relations (DNA → RNA → Protein) are collectively called
as “gene expression”. The cell changes its expressed set of genes according to
changing conditions and external signals. This results in a different set of func-
tional proteins in the cell, which also is key to differentiation in multicellular
organisms.
1.2.1 Transcription
Gene expression starts with transcription, which means production of mRNA
using a DNA template. This mRNA is later used as a template for protein
synthesis. Transcription is performed by the enzyme RNA Polymerase, a multi-
component protein, found in all living cells. RNA Polymerase binds to promoter
region of genes in the presence of specific transcription factors (TFs), and initiate
transcription at the start site (Figure 1.6).
TFs are DNA binding proteins that recognize specific binding regions in the
promoter or enhancer region of genes. In eucaryotes, TFs can be generic like
TATA Binding Factor (TBF), or can be specific, like STATs, targeting a restricted
set of genes. Each gene posesses binding sites of a specific set of TFs in their
promoter, thus needs presence of a specific set of factors for their expression.
At any given time, depending on the context and cellular stimuli, a tran-
scription factor will affect only of a subset of its all possible target genes. This
specificity is often provided by modulators, proteins that control transcription fac-
tor activity through several different mechanisms, including: post translational
modifications, protein degradation, and non-covalent interactions. Modulators
help a cell to combine different external signals and make complex downstream
decisions. Elucidating their function is necessary for understanding and control-
ling cell’s response to external stimuli at gene expression level.
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Figure 1.6: Sketches showing transcription of a gene. Top: RNA polymerase
recognizes the transcription initiation complex, formed by several transcription
factors and their binding proteins. Middle: RNA polymerase starts transcrip-
tion, reading the coding strand of the DNA and synthesizing mRNA. Bottom:
mRNA is synthesized and RNA polymerase dissociated from DNA [80]
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1.2.2 Expression Microarrays
The most popular way of detecting gene expression is to measure the mRNA
level of the gene. Since mRNAs in a cell are constantly produced and degraded,
mRNA concentration cannot last without an active transcription; thus it is an
indication of transcription. Translation phase is generally assumed by the pres-
ence of mRNA; however, there are studies showing that another kind of RNA,
microRNA, can interfere with and inhibit the translation process [54, 67].
Microarray technology is an advancement over the Southern Blotting tech-
nique for detecting DNA, and first described by [71]. Southern Blotting is very
similar to catching a fish, where the complementary DNA (cDNA) of the queried
DNA is bait, and fragmented DNA of the cell separated with gel electrophoresis
are the fish [73]. Bait is spread over DNA fragments, and catches (hybridizes
with) the DNA whose sequence is complementary. Excess bait is washed out,
remaining bait indicates the location of the DNA in query.
Microarrays detect expression of thousands of genes, sometimes the complete
genome of an organism, in a single experiment. The method uses DNA fragments
attached to a surface (array). Each spot on the array contains a specific DNA
sequence. The mRNA, extracted from the cell, are used for production of labelled
with fluorescence cDNAs, which are later hybridized with the DNA attached on
the microarray. Attached cDNAs are detected with laser scanning, measuring
signals coming from spots, each one indicating the expression level of a gene
(Figure 1.7).
There are two main types of microarrays, cDNA arrays and oligonucleotide-
arrays. cDNA arrays are historically first emerged type and use the whole ex-
pressed sequence as the probe. Each spot cDNA arrays is specific to a gene.
Oligonucleotide-arrays, on the other hand, use short oligomers – 25 to 60 bases
– in each spot. These oligomers are matched with fragments of genes, one gene
represented by several spots on the array. These arrays are mainly produced by
corporations Agilent and Affymetrix, they are relatively cheap, and most popular.
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Figure 1.7: Steps of a microarray experiment
Measured expression values are rarely used as is, since there is no standard
for normal expression of a gene. The most common method used for interpreting
gene expression is to perform the microarray experiment for two different con-
ditions, and compare expressions of the same gene in these conditions. If there
is a significant difference in the expressions, then the gene is said to be differen-
tially expressed. However, comparing just two arrays for assessing differentially
expressed genes would not be wise because expression values have high variation
due to the expreimental technique. It is said that, differential expressions can
be false positive up to 75% [2]. A way to overcome this problem is to perform
many microarray expreiments on the same condition and decide the expression
by evaluating collectively.
1.3 Contribution
In this thesis, we formulate several analysis methods for process description
graphs. Chapter 3 discusses the characteristics of process description graphs
and describes some graph traversal algorithms adapted to these graphs. We use
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these algorithms for answering several biologically relevant questions like paths
between molecules or common targets. We discuss the semantics of integrating
microarray data to pathways, and define the concept of causative paths that can
be used for elucidating dependencies between gene expressions through paths
on the network. In Chapter 4, we describe a probabilistic method, GEM [4],
for inferring and characterizing modulators of transcription factors based on ex-
pression profiles. We treat interacting molecules of transcription factors as po-
tential modulators, and use known targets of factors for measuring the depen-
dency of factor-target correlation on the modulator expression. In Chapter 5,
we present two tools, PATIKAmad [3] and ChiBE [5], that facilitate pathway
visualization and analysis. PATIKAmad is the microarray data integration com-
ponent of PATIKAweb [28]. ChiBE is a BioPAX pathway editor that represents
BioPAX graphs using the process description notation. It also supports local and
distant querying of BioPAX models in process description graphs; and adapts
PATIKAmad for expression data integration and analysis.
Chapter 2
Related Work
2.1 Biological Pathway Ontologies
Biological pathways are represented in many different forms, mainly determined
by the pathway provider itself. Databases that focus on a specific type of net-
work use a model which is simplest to fit their data. For instance Database of
Interacting Proteins (DIP) [69] represent their data in PSI-MI [41], which covers
molecule and interaction details (like reference or evidence), but cannot model
reactions, regulations or abstractions.
There are several efforts for integrating pathway data from different sources.
Such an effort have to use a model that can accommodate different types of infor-
mation. PATIKA project [24] defines such an ontology, and integrates pathway
data from BIND [6], HPRD [50], and Reactome [59] databases. BioPAX [25]
is another ontology, being developed with community effort, for modeling many
kinds of networks, and offered as a pathway exchange language. SBML [44] is
a similar project with a focus on simulation. SBGN [53] is another community
effort for determining standards of pathway graphical notation.
An extension of graph-based representation, namely hierarchically structured
or compound graphs, in which a member of a biological network may recursively
11
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contain a sub-network of other pathway elements, can be used for representing
sub-pathways, molecular complexes and subcellular location. Compound graphs
also help managing complexity by interactively decomposing a pathway into dis-
tinct components or modules [35, 23]. The recently introduced visualization stan-
dard SBGN [53] also uses compound graphs extensively.
2.1.1 PATIKA Ontology
In 2000, PATIKA project was launched to create a pathway visualization and
analysis platform with a comprehensive database. Towards this goal, the PATIKA
ontology [23], that models pathways in two levels of detail, was defined. Less de-
tailed first level (bioentity level) includes bioentities and their binary interactions,
while the second level (mechanistic level) models mechanistic details of events.
A molecule node in the mechanistic level is called state, and each state is
associated with a bioentity, which keeps references to the sequence databases
such as Entrez Gene [56] or UniProt [1], and to small chemical databases such as
ChEBI [22] or PubChem [15]. States represent molecular state of an entity in a
cellular location with some modification, like phosphorylation.
Events in the mechanistic level are modeled with transitions, which have sub-
strate, product, activator, and inhibitor edges that link transitions to states (Fig-
ure 2.1). Transitions have several types such as chemical modification, complex
formation, and transport.
Homologous states and transitions are modeled with homology abstractions
(Figure 2.2), and regular abstraction structure is used for defining any kind of
groupings, like pathways.
PATIKA ontology can also handle incomplete information using the model
elements incomplete state and incomplete transition (Figure 2.3). When any of
the incomplete element is associated with an edge, this means that this edge is
actually associated with one of the members of the abstraction, but we do not
know which one.
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Figure 2.1: Basics of PATIKA ontology [23].
Figure 2.2: Demonstration of the use of homology abstraction in PATIKA ontol-
ogy [23].
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Figure 2.3: When the associated state is not certain, but a candidate set exists,
incomplete states are used in PATIKA ontology for representing this information.
T1 in the drawing is an incomplete state, indicating either S1 or S1′ inhibits the
reaction [23].
2.1.2 BioPAX
BioPAX (Biological Pathway Exchange Language) project was initiated for cre-
ating a common format that will facilitate the data transfer between biological
pathway databases. Each version of BioPAX language is called a level. The first
BioPAX level (level 1) is released in 2004, modeling biochemical reactions (Fig-
ure 2.4). Their model associates PhysicalEntity objects (molecules) to Con-
versions through utility objects called PhysicalEntityParticipant, which also
keeps stoichiometry, cellular location, and chemical modifications of the associ-
ated PhysicalEntity. Level 2 was released with an extension to include physical
interactions between molecules.
BioPAX level 3 improves over the previous levels by explicitly putting molecu-
lar states in the model. This level completely abandons PhysicalEntityParticipant,
and changes semantics of PhysicalEntity to represent molecular states in-
stead of entities, and semantics of previous PhysicalEntity class migrates to
EntityReference (Figure 2.5). Level 3 also supports gene regulatory interac-
tions and genetic interactions. Figure 2.6 shows the progress of BioPAX language
over time.
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Figure 2.4: Part of the data model of BioPAX Level 1.
Figure 2.5: Part of the data model of BioPAX Level 3.
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Figure 2.7: A manually drawn pathway appeared in [42].
2.1.3 SBML
SBML [44] was developed as a modeling standard for pathways at the level of
biochemical reactions. Focus of SBML is simulation of the modeled events; thus,
their model is very low level. Each pool of chemically identical molecules in
a specific cellular compartment is represented with a Species, which are also
inputs and outputs of the Reactions. SBML has structures for reaction rules
and parameters, while it completely ignores any generalizations or incomplete
information.
2.1.4 SBGN
Biological pathways are generally visualized using graphical models. Most graph-
ically pleasing pictures are still manually drawn ones that generally appear in
published materials. However, these nice pictures generally lack a consistent no-
tation, and it is impossible to understand them without an explanatory text. For
instance, the graph in Figure 2.7 describes regulation of Stat signaling by ITAM-
dependent pathways [42]. Two arrows that go to Stat1 have completely different
meanings. One edge is for the activation of Stat1, while the other is helping this
event, which we only understand after reading the related paper.
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SBGN [53] is a standardization effort for pathway drawings. It aims the draw-
ings to be self-explanatory and to cover most of the biological phenomena. SBGN
defines three kinds of drawings: process diagrams, entity relationship graphs, and
activity flow graphs. For each graph type, several glyphs are defined as units of
the notation. Process diagrams (Figure 2.8) explicitly draw processes with par-
ticipant molecular states. This graph type is most similar to the notation used
by popular pathway databases like Reactome, KEGG, and PATIKA. Entity re-
lationship diagrams (Figure 2.9) draw each entity once, and show processes by
edges between entities, their features, and other edges.
2.2 Pathway Editors
A limited number of software tools for biological pathway visualization and anal-
ysis was developed such as Cytoscape [51], CellDesigner [36], PATIKAweb [28],
Pathway Tools [49], and VisANT [43]. These tools differ in their focus and ca-
pabilities. Several of these tools are compared in Table 2.1 with their support
to BioPAX and SBGN standards, layout capability, compound graph support,
availability and type of software. More details about Cytoscape, CellDesigner,
and PATIKAweb are given below.
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Figure 2.8: Stimulation events in the neuro-muscular junction, drawn as a SBGN
Process Diagram [70].
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Figure 2.9: SBGN entity relationship diagram describing the effect of a depolar-
ization (dV) on the intracellular calcium, that binds to calmodulin, that itself
binds to the calcium/calmoduline kinase II (CaMKII) [70].
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2.2.1 Cytoscape
Cytoscape is an open source pathway editor, based on yFiles graph editing frame-
work. The project aims the tool to be easily extendable by plugins, so that re-
searchers can write their own analyzers for pathways. Today, there are many
Cytoscape plugins, written by different groups, implementing a diversity of path-
way analysis algorithms 1.
One pitfall of Cytoscape is that they do not make use of compound graphs,
so they have an unusual way of representing complex molecules (Figure 2.10).
Cellular locations are shown as text next to the name of the related molecule.
2.2.2 CellDesigner
CellDesigner [36] is a diagram editor for drawing gene-regulatory and biochemical
networks. They use SBGN Entity Relationship and Process Diagram representa-
tions in drawings (Figure 2.11), and they can save the created models in SBML
language. CellDesigner lets user to adjust kinetic parameters of the reactions and
concentrations of the molecules, and performs simulations on the model.
2.2.3 PATIKAweb
PATIKAweb [28] is the front-end of the PATIKA database [24]. It is a web
based pathway editor, which was built on JSP (JavaServer Pages technology)
edition of the Tom Sawyer Visualization technology. Pathway representations are
similar to SBGN Process Diagrams. PATIKAweb draws pathways on a cell model;
i.e., drawing area is divided into compartments representing cellular locations
(Figure 2.12). The tool uses compound nodes for displaying molecular complexes,
homologies, and abstractions. Graphs are laid out using the CoSE algorithm [29],
specially designed for graphs with compound structures.
1For a complete list of plugins, refer to [21]
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Figure 2.10: Cytoscape pathway showing dissociation of CAV1 from a big com-
plex.
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Figure 2.11: A screenshot of CellDesigner [14].
Figure 2.12: PATIKAweb view of the pathway “Valine Catabolism”.
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2.3 Reverse Engineering of Gene Regulatory
Networks
Identification of a gene’s regulatory process with controlled experiments is a costly
procedure, which requires experiment setups that should involve the gene’s pro-
moter with a reporter, and all related transcription factors and their potential
modulators. Since it is not practical to test all potential regulators in com-
binatorially many settings, studies generally focus on few regulators in limited
conditions.
Gene expression microarrays can measure expression levels of all genes in
a specific condition, thus have potential to provide insights on dependencies of
genes to each other for expression. There are many studies that try to re-construct
the gene regulatory network using large numbers of expression data. A review
by Margolin and Califano [57] classifies reverse engineering methods as linear,
probabilistic, and information theoretic, basis of which are summarized below.
All of these methods assume that expression of a gene is a function of other
genes, and expression of genes are indicator of their protein activity.
2.3.1 Linear Models
Gene expression at time t+1 can be formulated as the linear combination of other
genes’ expressions at time t plus some constant (Eq. 2.1).
xt+1i =
∑
j
ajx
t
j + ci (2.1)
X t+1 = A×X t + C (2.2)
The relation is more formally represented using matrices, like in Eq. 2.2,
where, X is the gene expression vector of size n, A is a n × n matrix, and C is
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the constants vector of size n. This formulation comes natural when worked on
time-series expression data, where samples in the expression dataset belong to
equally distributed time intervals, starting after a perturbation is applied to the
system.
2.3.2 Probabilistic Models
Probabilistic frameworks try to estimate a probability of expression for the gene
under condition of the expression status of other genes. The most popular prob-
abilistic framework is the Bayesian network, which is a directed acyclic graph,
where nodes represent gene expression statuses and edges represent dependencies
between expressions. A sample formulation is given in Eq. 2.3, where xi is the
expression status of the ith gene, pii,j represents the j
th parent of ith gene, ai,j is
the weight of the effect of jth parent on ith gene.
P (xi) =
∑
j
ai,jpii,j + ci (2.3)
Probabilistic approaches are generally applicable when gene expressions can be
discretized, like high and low. While working on steady-state expression datasets
of differing conditions, probabilistic framework is easier to use than a linear sys-
tem because of absence of time in the formulation.
2.3.3 Information Theoretic Models
The information theoretic measure, mutual information (MI), can capture the
dependency between gene expressions. MI is calculated using independent and
joint entropies of gene expressions as in Eq. 2.4, where, S is the information
theoretic entropy, and Xi is the expression vector of the i
th gene.
MIi,j = S(Xi) + S(Xj)− S(Xi, Xj) (2.4)
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MI is similar to Pearson correlation in the sense that it measures a kind
of dependence between variables; however, Pearson correlation assumes a linear
relationship between variables while MI measures any kind of dependence. MI is
guaranteed to be non-zero unless variables are statistically independent.
2.4 MINDY - Identifying Transcription factor
modulators
Wang et al. propose an information theoretic approach for inferring modulators
of transcription factors (TFs) from microarray data. They measure the mutual
information between the TF and the target gene (t), conditional to the modulator
candidate (M ); i.e., CMI(TF, t|M). The mutual information between TF and
the target gene indicates dependency of expression of the target gene on the
expression of the TF. In the presence of a modulation, they expect this value
to be different in low and high values of the modulator (Eq. 2.5), and infer
modulators with a high ∆CMI.
∆CMI = CMI(TF, t|M+)− CMI(TF, t|M−) (2.5)
They test their method on B cells, 254 expression profiles, and identify modu-
lators of Myc oncogene. They test all genes as potential targets, and all signaling
proteins and other TFs as potential modulators. Low and high values of a mod-
ulator are determined by rank-ordering the expression data values, selecting first
quartile as low and third quartile as high, and not using the second quartile.
Among 542 signaling proteins and 598 transcription factors, MINDY identifies 91
signaling proteins and 99 TFs as modulators of Myc.
Chapter 3
Analysis of Process Description
Graphs
This chapter provides the theoretical basis for pathway analysis as implemented
in the software tools PATIKAmad and ChiBE.
3.1 Basics
Let G = (V,E) be a graph with a non-empty node set V and an edge set E. An
edge, e = x, y or simply xy, joining nodes x and y is said to be incident with
both x and y. Node x is called a neighbor of y and vice versa. A pathway graph
G = (V,E) is a graph, where some of the edges in E are marked as inhibition
edges (e.g., an interaction that disables or impedes the target reaction node via
the source state node).
A path between two nodes n0 and nk is a non-empty graph P = (V
′, E ′) with
V ′ = n0, n1, ..., nk and E ′ = n0n1, n1n2, ..., nk−1nk, where ni are all distinct. n0
and nk are called the end points of path P = n0n1...nk, whose length, denoted by
|P | is the number of edges on it. A path is said to be directed if all its ordered
edges are directed in the same direction. A directed path P is called an incoming
28
CHAPTER 3. ANALYSIS OF PROCESS DESCRIPTION GRAPHS 29
(outgoing) path of node n if P ends at target (starts at source) node n. A directed
path is called positive (negative) if it contains an even (odd) number of inhibitors
(i.e., inhibition edges).
Given node sets A and B, an A−B path is a path with its ends in A and B,
respectively, and no node of P other than its ends is from either set A or B. An
A − path is a path where one of its end nodes is in A, and no other nodes and
interactions are from A.
The graph-theoretic distance dG(x, y), between two nodes x and y in graph
G, is the length of a shortest x − y path in G. If G′ = (V ′, E ′) is a subgraph of
G = (V,E), and G′ contains all the edges xy ∈ E with x, y ∈ V ′, then G′ is an
vertex-induced or simply induced subgraph of G; we say that V ′ induces G′ in G
and write G′ = G[V ′]. If node x is the starting node of a directed path that ends
up at node y, then node y is said to be in the downstream of node x; similarly,
node x is said to be in the upstream of node y. A node y in the downstream of a
node x is a potential target of x; similarly, x is a potential regulator of y.
The graph type assumed in the rest of this Chapter (except section 3.5) is bi-
ological graphs that are similar to PATIKA mechanistic graphs or SBGN process
diagram, which we call process description graph. The characteristic property
of such graphs is that they follow the biochemical reaction paradigm, events are
represented with a special node type (transitions in PATIKA), molecule nodes,
or states, are related to the events through input, output, and effector relations
(Figure 3.1).
Edges in a process description graph always have a direction. When two states
are connected through a directed path, this implies that the state at the start of
the path can have influence on the existence (or concentration) of the state at
the end of the path. For instance, in Figure 3.1 the path from S1 to S4 implies
that concentration change of S1 can affect the concentration of S4. Because of
the presence of such a path, we say that S1 is at the upstream of S4, and S4 is at
the downstream of S1.
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Figure 3.1: Sample process description graph with three different node types and
5 different edge types. Direction of the edges without an arrow is from the state
to the non-state node. Green edge is for activation, while red edge represents
inhibition.
Only the effector edges in a process description graph can be negative. In Fig-
ure 3.1 S1 is at the positive upstream of S4, and S4 is at the negative downstream
of S5.
3.2 Visualization of BioPAX Using Process De-
scription Graph
BioPAX language have some structural differences from process description
graphs, which needs a conversion before visualization and analysis. BioPAX
level 2 uses PhysicalEntityParticipant (PEP) objects as a link from
PhysicalEntity (PE) to Interaction (Conversion and Control) objects. PEPs
in BioPAX are not reusable objects, they are created per interaction, because PEPs
also store the stoichiometry information which is specific to the Interaction.
During conversion, each PEP that has the same modification features and the
same cellular compartment corresponds to a unique state in process description
graph (Figure 3.2).
Conversion in BioPAX can be bidirectional (reversible), however a transition
in process description graph is strictly unidirectional. Any reversible Conversion
in BioPAX is represented with two transitions in process description graph (Fig-
ure 3.3).
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Figure 3.2: PEPs in BioPAX level 2 graph are grouped according to their modifi-
cations and cellular locations during conversion. Each group is represented with
a unique state in the process description graph.
Figure 3.3: Reversible Conversion in BioPAX is represented with two transitions
in process description graph.
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Figure 3.4: Desired distance labeling in a process description graph when states
are in focus of the traversal. Nodes and edges on the S1-S3 path is labeled
according to the distance from S1 (upper labels, forward distance), or distance
from S3 (lower labels, backward distance). Distances are defined between states,
however, there are advantages of defining distance labels for all nodes and edges.
For instance, the sum of forward distance and backward distance of a node or
edge on the S1-S3 path is equal to the state-based length of the path, which is 2.
3.3 Paths and Distances
Distances between nodes are often used in graph traversal algorithms. For in-
stance the breadth-first search (BFS) guarantees that no node in distance i + 1
will be traversed before all nodes in distance i is traversed. When a graph has
a single type of node and a single type of edge, distance between two nodes is
simply calculated by the number of the edges on the path that connects them.
However, when node and edge types are multiple, distances between a node type
of focus can be different from the graph theoretical distance. In that case, we
need to modify graph traversal algorithms to run using the specific node-based
distance.
In process description graphs, molecular states are connected through other
non-state nodes, like transition and control nodes. When the focus of a traversal
algorithm is the molecular states on the network, it needs to define the distance
as the distance between states. For instance in Figure 3.1, S5 – the upstream
inhibitor of S4 – has a graph theoretic distance of 3 from S4. However, S5 is an
immediate inhibitor of S4, and the state-based distance is 1.
Figure 3.4 shows an example state-based distance labeling on a path whose
graph theoretical distance is 5. The state-based distance from S1 to S3 is 2
because they are connected by 2 events. Here, the non-state nodes and edges
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between states get the label of the state at their upstream. Upper labels in the
figure show a forward labeling, i.e, distance from S1; while the lower labels show a
backward labeling, i.e., distance from S3. The sum of forward label and backward
label of an object on the path is equal to the state-based length of the path, which
is 2 in this example.
3.4 Querying Paths on a Network
We previously designed a graph-theoretic querying framework, answering
some important biological questions for PATIKA (mechanistic and bioentity)
graphs [27], such as neighborhood, shortest path, graph of interest, paths of in-
terest, and common stream. Algorithms implemented in this framework did not
have to consider the heterogeneity of node types because PATIKA mechanistic
graphs are bipartite; thus state-based distance of a path is always half of its graph
theoretic distance.
Here we generalize these algorithms to process description graphs, which are
not necessarily bipartite; however, node types can be labeled as state and non-
state. All these algorithms are based on breadth-first search (BFS), so we first
modify the well-known BFS to use the state-based distances in process description
graphs, and then build other algorithms on this modified BFS.
3.4.1 BFS for Process Description Graphs
Algorithm 1 is a modified BFS, where search starts from the source set S, ends in
target set T, runs in the direction specified by dir parameter, and continues until
the limit distance k is reached. If there is no target set, T can be left empty; and
if there is no search distance limit, k can be defined as infinite. The complexity of
this modified BFS is the same with the ordinary BFS, which is O(|V |+ |E|) time
complexity, where |V | and |E| are the number of nodes and edges, respectively.
The difference of this BFS from the regular BFS is that breadth is defined
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with the closest level of states. This is realized by using a priority queue instead
of a regular queue. States are added at the end of the queue to be processed at
as the next breadth (line 25), while non-state nodes are added at the head of the
queue to be processed immediately (line 27). This BFS also uses a state-based
labeling, like the labeling in Figure 3.4. It increments labels only when reaching a
state from an edge during forward traversal (line 18), and when reaching an edge
from a state during backward traversal (line 12). The algorithm uses color labels
for the processing statuses of nodes: white means not processed, gray means in
queue, and black means processed. The algorithm assumes initial node colors are
white.
3.4.2 Neighborhood
Neighborhood of a set S of source nodes is defined as:
NB(S, k) = S ∪ {x | x is a node on a S-path P, and |P | ≤ k}
∪ {e | e is an edge on a S-path P, and |P | ≤ k}
Upstream or downstream neighborhoods of states in a process description
graph can be queried with simple BFS calls (Algorithm 2).
3.4.3 Paths of Interest
Simplest strategy for searching relations between states is to search paths in
between. We define the paths-of-interest (PoI) algorithm for searching paths
between two given sets of states – source set S, and target set T – within a search
distance limit k. This algorithm does not enumerate paths, but returns a merge
graph of the related paths. Paths-of-interest is formally defined as:
PoI(S, T, k) = G [B] , where B = {x | x is on a S-T path P, and |P | ≤ k}
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Algorithm 1 BFS(S, T , dir, k)
Require: dir is fwd or bkwd
Require: S and T contain only state-node
1: for all vertex n ∈ S do
2: n.color ← gray
3: n.label(dir)← 0
4: Q← ∅
5: R← S
6: Q.enqueue(S)
7: while Q 6= ∅ do
8: u← Q.dequeue()
9: for all incident edge e of u going in dir do
10: R← R ∪ {e}
11: if dir = bkwd and u is state-node then
12: e.label(dir)← u.label(dir) + 1
13: else
14: e.label(dir)← u.label(dir)
15: n← e.otherEnd(dir)
16: if n.color = white then
17: if dir = fwd and n is state-node then
18: n.label(dir)← e.label(dir) + 1
19: else
20: n.label(dir)← e.label(dir)
21: R← R ∪ {n}
22: if n /∈ T and (n.label(dir) < k or n is not state-node) then
23: n.color ← gray
24: if n is state-node then
25: Q.enqueue(n)
26: else
27: Q.addF irst(n)
28: else
29: n.color ← black
30: u.color ← black
31: return R
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Algorithm 2 Neighborhood(S, dir, k)
Require: dir is fwd, bkwd, or both
1: R← ∅
2: if dir = fwd or dir = both then
3: R← R ∪BFS(S, ∅, fwd, k)
4: if dir = bkwd or dir = both then
5: R← R ∪BFS(S, ∅,bkwd, k)
6: return R
Algorithm 3 PoI(S, T , k)
1: C ← BFS(S, ∅, fwd, k)
2: ResetColors(C)
3: C ← C ∪BFS(T, ∅,bkwd, k)
4: R← ∅
5: for all vertex u ∈ C do
6: if u.label(fwd) + u.label(bkwd) ≤ k then
7: R← R ∪ {u}
8: return R
An alternative version of the PoI algorithm uses the shortest path distance
between source and target sets as the search distance limit. This is useful espe-
cially when we do not have any idea on the distances from S to T, so we can not
provide a realistic k. So, we define the algorithm PoI-Shortest, searching paths
from S to T using a length limit shortest + k (Algorithm 4). Both PoI and
PoI-Shortest algorithms have O(|V |+ |E|) time complexity.
Algorithm 4 PoI-Shortest(S, T , k)
1: C ← BFS(S, ∅, fwd,∞)
2: ResetColors(C)
3: C ← C ∪BFS(T, ∅,bkwd,∞)
4: R← ∅
5: sd← min(u.label(fwd) + u.label(bkwd)) where u ∈ C
6: for all vertex u ∈ C do
7: if u.label(fwd) + u.label(bkwd) ≤ sd+ k then
8: R← R ∪ {u}
9: return R
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3.4.4 Graph of Interest
Often times researchers do not have source and target sets to search a relation in
between, but they have just a set of states, and want to learn if they are related.
We define the graph-of-interest (GoI) algorithm for searching any path between
a given set of states, within a search distance k, which is in fact a PoI call using
the state set as both source and target (Algorithm 5). GoI is defined as:
GoI(S, k) = G [B] , where B = {x | x is on a S-S path P, and |P | ≤ k}
GoI can alternatively use PoI-Shortest for searching paths within a distance
of shortest+ k.
Algorithm 5 GoI(S, k)
1: return PoI(S, S, k)
3.4.5 Common Stream
There are already a number of algorithms for inferring highly connected or co-
regulated subnetworks of cellular interactions and processes often called modules
or pathways [13, 81, 9]. When analyzing these modules, we often want to know
if there is a process or gene that is upstream of the genes in the module, which
can provide a causal explanation for the co-regulation, and ultimately a way to
control the module. Similarly, two pathways affecting the same mechanism in
the cell is interesting since it suggests that a specific phenotype can have more
than one molecular cause. For instance, Engelman et al. [31] discuss that drug
resistance in lung cancer is related to an alternative pathway that leads to PI3K
activation. Searching for common targets of signaling proteins can help to develop
alternative treatment strategies.
Common downstream (upstream) of a source entity set S is the set of poten-
tial common target (regulator) entities that are in the downstream (upstream) of
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all entities in S. We describe the common-stream algorithm for identifying com-
mon upstream and downstream (determined by dir parameter) within a search
distance limit k (Algorithm 6). Common downstream is defined as:
CD(S, k) = {x | ∀a ∈ S (∃P | P is a path from a to x, and |P | ≤ k)}
Common upstream is defined similarly. The algorithm simply executes a BFS
search from each source node and increment reached count of the nodes in the
resulting BFS tree. When a node is reached from all of the source nodes, it is
collected in the resulting common stream. This algorithm has O((|S|×|V |)+ |E|)
running time complexity.
Algorithm 6 CommonStream(S, dir, k)
Require: dir can be fwd or bkwd
1: C ← R← ∅
2: for all vertex u ∈ S do
3: C ← BFS({u} , ∅, dir, k)
4: for all vertex n ∈ C do
5: n.reached← n.reached+ 1
6: ResetLabel(C, dir)
7: ResetColor(C)
8: for all vertex v ∈ C do
9: if v.reached = |S| then
10: R← R ∪ {v}
11: return R
3.4.6 Inter-Compartment Paths
A signal in or outside of the cell is transmitted through cellular locations towards
its destination. This is mainly controlled through receptors on the boundary sur-
faces of compartments, and carrier molecules that assist other molecules in their
transmission. Paths between different cellular locations often capture these sig-
naling events. We define Inter-compartment-paths query (Algorithm 7) as a spe-
cial application of paths-of-interest query. This query executes a paths-of-interest
query from states in a compartment to the states in the other compartment.
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Algorithm 7 InterCompartmentPaths(compartment 1, compartment 2, k)
1: S ← states in compartment 1
2: T ← states in compartment 2
3: return PoI(S, T , k)
3.5 Expression Data on Pathways
Microarray experiments take a snapshot of the cell, showing expression of almost
the entire genome. Since gene expressions can be affected from their upstream
in a cellular network, and since they can affect expression of their downstream,
analyzing expression data on pathways can be informative. One of the simple
way of integrating expression data with pathways is visualization of data values
on the molecule nodes of the network.
Visualization of expressions on pathways needs a mapping from expression
values to molecules in the pathway. This mapping can be obtained by matching
external references on the expression data and pathway. However, often times
more than one row of expression data match with a molecule on the pathway,
and these rows can have dramatically different values. Presence of multiple rows
per gene is generally due to presence of several isoforms of that gene, which are
measured separately on the expression profile. The most accurate way of visual-
ization in that case is to represent all the related values on the molecule nodes;
however, this is generally not a practical solution because of space limitation and
increasing visual complexity of the pathway drawing. An approximation is to dis-
play only the highest value that is matched with the molecule; so that we define
expression of a gene as the expression of at least one of its isoforms. This ap-
proximation fails when isoforms have different functions, but this time the cause
of the failure is not incorrect mapping but absence of sufficient details on the
network.
Expression data is a measure for the concentration of RNA molecules in the
cell. Thus, the correct way of mapping is to map expressions to RNA states on
the network. Unfortunately, RNA states are highly under-represented in popular
pathway databases. Representing expressions on the protein states is the next
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option, and applied by several pathway editors [51, 5]. When represented on
proteins, expression values tend to be interpreted as indicators of protein levels,
or activities in the cell. This is a kind of an approximation ignoring translational
and post-translational control of proteins, which is probably wrong in many cases,
requiring caution when used.
Visualizing a single profile is generally not very informative since expression
values do not tell much about activity of gene products. However, comparisons
between two profiles tell many things; a change in expression values is often
interpreted as a change of activity of gene products in the same direction.
3.6 Causative Paths
Pathway databases contain information about possible interactions and reactions
between molecules in a cell. Usually, this data is created by manually curating
biological literature and can span multiple experiments from different tissues,
organisms and contexts. When taken as an interconnected network, these inter-
actions and reactions offer a causal model of a cell’s response to stimuli. For
instance, in a typical microarray experiment, relatively small portions of this
network are differentially active between the control and the sample, and deter-
mining these parts can be extremely useful for finding causal explanations for the
correlations observed in the data.
Change of an expression value can be related to change of other gene expres-
sions through a path in the cellular network. If a path in the network potentially
explains expression change of the end-state with the expression change of the
start-state, then we call it a causative path.
The last transition in a causative path should be a transcription, or should at
least be related to gene expression. A positive causative path will have similar
expression changes at its start-state and end-state. Similarly, a negative path can
be causative only when it has different expression changes at its start-state and
end-state (Figure 3.5).
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Figure 3.5: Examples of two causative paths. Red state: upregulated, blue state:
downregulated. Transitions with label t are transcription events. Red edge:
inhibition, green edge: activation.
Chapter 4
Discovering Modulators of Gene
Expression
Our current knowledge of the modulation of transcription factors comes mainly
from experimental studies that measure the expression levels of a few target genes
(such as [62] and [66]) or the expression level of an artificial reporter gene with a
“canonical promoter” (such as [77]). While these experiments provide invaluable
insight, they do not tell the whole story. In order to detect context-dependent,
target-specific effects of modulators, system-scale methods are required. Gene
expression profiles are now extensively used for inferring causal relationships be-
tween transcription factors and target genes. The models produced from gene
expression profiles, often referred as “gene regulatory networks”, or simply “gene
networks”, differ significantly in their semantics and level of detail. Margolin and
Califano [57] provide a comprehensive review of these methods and classify them
under three groups: linear, graph-theoretic, and information-theoretic models
(Section 2.3). The majority of these methods focus on modeling either causal
relationships between gene expression levels as binary interactions, or linear in-
tegration of expression values.
Expression level of genes can also be affected by non-modulator proteins such
as alternative transcription factors, generic inhibitors of transcriptional machinery
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or regulators of mRNA degradation. A modulator is defined by its dependency
on the transcription factor in order to exert its effect on the target. When the
transcription factor is not present, at least a part of the modulator activity should
be rendered ineffective. This implies a ternary, non-linear relationship, analogous
to the electrical transistor, between the activity levels of the two “inputs”, the
transcription factor and the modulator, and the “output”, the target gene expres-
sion. Using a sufficiently large set of expression profiles, these relationships can
be detected by looking at the correlations between expression levels of candidate
modulators with the expression level of a transcription factor and its target genes.
Assuming that the expression level is an indicator of modulator and transcription
factor activity, the dependency between modulator and target expression must
increase as the concentration of the transcription factor increases. Therefore, we
expect to observe a transcription factor-dependent correlation between modulator
and target.
Wang et al. [76] propose MINDy, an information theoretic algorithm for de-
tecting modulators. They test the conditional mutual information (CMI) between
the transcription factor and the target gene, and its dependency on the modula-
tor candidate (Section 2.4). This is, in essence, the aforementioned non-linearity
principle. Building upon the same principle, we present GEM (Gene Expression
Modulation) [4], a probabilistic method for detecting modulators of transcription
factors using a priori knowledge and gene expression profiles. For a modulator /
transcription factor / target triplet, GEM predicts how a modulator-factor inter-
action will affect the expression of the target gene. GEM improves over MINDy
by detecting two new classes of interaction that would result in strong corre-
lation but low ∆CMI, can filter out logical-or cases and offers a more precise
classification scheme. A detailed comparison of GEM and MINDy is provided in
Section 4.2.2.
In the following sections, we explain our method and assumptions and apply
GEM to predict modulators of Androgen Receptor (AR). We compare our results
with a recent literature review on modulators of AR and show that GEM correctly
predicts a significant number of its modulators and can provide additional insight
into the mechanism of modulation and affected targets. We observe that these
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Figure 4.1: Left: GEM is based on a simple model of gene regulation. A mod-
ulator interacts with a transcription factor to affect the expression of a target.
Right: Initial hypotheses are generated by combining known protein-protein and
protein-DNA interactions which are then tested against a set of gene expression
profiles.
modulators cannot be easily classified into co-activator/co-repressor categories.
Most modulators will selectively increase the expression level of some AR targets
while decreasing the others, a property we call bimodality.
4.1 GEM Method
GEM uses three types of input, protein-protein interactions, transcription factor-
target relations, and gene expression profiles. Proteins that are known to in-
teract with the transcription factor are considered as potential modulators and
transcription factor-target binding data are used to obtain a list of target genes
for each transcription factor. These two types of interactions are combined to
build a large number of small causal hypotheses of the form: “Modulator pro-
tein M, via transcription factor F affects the expression of the target gene T ”.
The modulator hypothesis predicts that correlation between the expression levels
of the modulator and the target must change as the level of transcription factor
changes. We use this dependency as a metric of the interaction between the mod-
ulator candidates and the transcription factor to select most likely modulators
(Figure 4.1).
We can estimate this relation with the following model:
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E(t) = hc + hm(m) + hf (f) + g(m, f) (4.1)
Where, m, f and t are expression levels of the modulator, transcription factor,
and target, respectively. E(t) is the expected value of t. hm and hf represent the
effect of m and f, respectively, on t by themselves alone (main effects), while g
represents the effect of their interaction. If interaction of m and f has an effect
on t, we expect g to be non-zero.
There is reason to believe that hm and hf can be approximated with linear
functions [17]. On the other hand, the nature of g can vary significantly from
triplet to triplet, and cannot be covered by a single class of continuous functions.
If g is monotonic, however, we can use a discrete model such as the one described
by Wang et al. [76]. This allows us to look for non-zero g components without
worrying about the actual mechanism. When we transform the expression values
of genes to activity levels 0 and 1, our model becomes:
P (t′ = 1) = αc + αmm′ + αf f ′ + γm′f ′ (4.2)
Given a set of expression profiles, we estimate alpha coefficients by calculating
the observed proportions of t′ = 1, conditional on m′ and f ′. We then select
triplets with a high γ coefficient that satisfy a false discovery rate threshold after
multiple hypothesis testing correction.
A high γ alone, however, is not sufficient to infer modulation. Some non-linear
relationships, such as logical-or of M and F cannot be explained by modulation.
To remove these false positives, and to infer the mode of action of the modulator,
we classify the non-linear triplets based on their proportion patterns and select
those that can be explained by a simple, direct modulation. We report these
modulators along with their respective targets and their mode of action.
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4.1.1 Construction of Triplets
To construct our initial set of hypotheses, in the form of a modulator-factor-
target triplet, we combine existing protein-protein and transcription factor-target
interactions. Proteins known to interact with a transcription factor, but not
targets of the factor themselves, are considered as potential modulators for all
targets of the transcription factor. Large integrated protein-protein interaction
datasets are already available [50], and known targets of transcription factors can
be obtained from literature curation [45] [60], sequence based prediction [45], and
ChIP-Chip experiments [11].
4.1.2 Selection of Expression Data
Using gene expression profiles we can directly measure the level of expression for
target genes and estimate activities of M and F from their expression levels. For
this estimation to be accurate, expression profiles must satisfy the following two
conditions:
• There is a steady state expression level for genes. A change in the expression
levels of M and F will be reflected in their protein abundance and expression
after a delay. Without steady state property, we cannot correlate m, f, and
t in the same expression profile.
• Expression levels of M and F are correlated with their protein abundance.
Studies demonstrated that there is a lower correlation between expression
levels and protein abundance than expected [39]. This correlation, however,
increases significantly if the variance of expression values are high.
In addition to these conditions, f and m should have sufficient variance in the
expression dataset. If one or both genes have relatively constant expression, then
this may cause three problems:
• A low correlation between mRNA and protein abundance is expected.
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• There will not be enough “perturbation” in the data set to infer M and F ’s
effect on T.
• There is a possibility of detecting fine-tuning feedback loops as modulations.
Ideally, m and f should have high variation and low correlation in the samples.
Gene expression profiles of 2158 human tumor samples published by expO
(Expression Project for Oncology) is currently the best publicly available dataset
for our purposes [32]. The variety of tumor samples used in this study increases
variation and thus helps reduce correlations between m and f due to the context.
There are, however, some genes in the expO set that have inadequate variation
in their expression levels (variation of log values less than 1) and these are left
out of our analysis.
4.1.3 Discretization and Conditional Proportions
We divide rank-ordered expression values of a gene by tertiles and further dis-
cretize the triplets using:
x′ =

1, if x is in upper tertile
null, if x is in middle tertile
0, if x is in lower tertile
(4.3)
This simple strategy has been shown to maximize entropy among groups [18]
and is similar to the one used by Wang et al. We also explored more sophisticated
(and computationally expensive) strategies including dynamically determining
optimal threshold for each triplet that maximizes entropy; however, these did not
yield substantial changes in our results.
After discretization, each experiment falls into one of the 27 possible bins
based on the ternary state of m′, f ′, and t′ (Figure 4.2, Left). While calculating
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Figure 4.2: Left: Samples are ranked and divided into 27 possible bins. Samples
with middle values are discarded and frequencies from 8 “corner” bins are used for
the rest of the analysis. Right: For each combination of m,f states, proportions
of t being high are derived from frequencies. Pairwise differences of proportions
provide estimates for α and β values.
the interactions, we only consider the 8 bins, where none of the genes has null
value. Observed frequencies of these states are denoted by fˆm′,f′,t′ .
We then calculate the proportions of t′ = 1 for each combination of states of
f ′ and m′:
pˆm′,f′ =
fˆm′,f′,1
fˆm′,f′,0 + fˆm′,f′,1
(4.4)
4.1.4 Selection of Significant Triplets
Observed proportions are conceptually similar to biological experiments. pˆ1,1 is
our test case, where both f and m are high; thus, an interaction is expected. pˆ0,0,
pˆ1,0 and pˆ0,1 are the controls; here, we do not expect an interaction to occur as
at least one of the interacting partners is missing.
By using the differences of observed proportions we can estimate the α coef-
ficients in Eq 4.2 (Figure 4.2, Right):
CHAPTER 4. DISCOVERING MODULATORS OF GENE EXPRESSION 49
αˆc = pˆ0,0 (4.5)
αˆf = pˆ0,1 − pˆ0,0 (4.6)
αˆm = pˆ1,0 − pˆ0,0 (4.7)
We can also estimate the effect of F and M when their interacting partner is
present:
βˆf = pˆ1,1 − pˆ1,0 (4.8)
βˆm = pˆ1,1 − pˆ0,1 (4.9)
Finally, γˆ gives us a metric for the effect of interaction:
γˆ = βˆf − αˆf = βˆm − αˆm = pˆ1,1 − pˆ0,1 − pˆ1,0 + pˆ0,0 (4.10)
Any significant triplet must have a non-zero γˆ. This, however, is not sufficient,
as a synergistic effect can result from relationships other than direct modulation.
For example, consider the case where M and F are two transcription factors com-
peting for the same binding site to activate expression of T. When F is high, there
will be low M-T correlation – a non-linear relation which might have significant
γ. Such cases occur when effects of M and F are similar but independent, and
there is a cap on the T expression levels due to a third factor, such as the DNA
binding site. The nature of such a relationship between M and F is a logical-or
as opposed to logical-and in modulation. Although interesting, we can not apply
our statistical inference to these relationships due to the hidden third factor.
If M is affecting T directly through F, it must be active when F is high. More
formally, βˆm must be significantly different than zero, and must either have a
larger absolute value or have a different sign than αˆm.
As a result, all of the following null hypotheses must be rejected for a triplet
to be inferred as a direct modulation:
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H1 : γ = 0 H2 : βm = 0 H3 :
αm
βm
≥ 1 (4.11)
4.1.5 Significance of the Difference of Proportion Pairs
α and β values are estimated using independent proportions p0,0, p0,1, p1,0 and
p1,1 (Eq. 4.6 - 4.9). When M and F has no effect on T expression, these propor-
tions will be approximately normally distributed with mean zero. Similarly, the
difference between two proportions are approximately normally distributed with
mean zero when the change in the conditions does not have an effect on T.
Each pi,j was calculated using frequencies as in Eq. 4.12.
pi,j =
fi,j,1
ni,j
(4.12)
ni,j = fi,j,0 + fi,j,1 (4.13)
The variance of proportion difference pi,j − pk,l is estimated in Eq. 4.14 [34].
V ar(pi,j − pk,l) = pijkl qijkl ( 1
ni,j
+
1
nk,l
) (4.14)
pijkl =
fi,j,1 + fk,l,1
ni,j + nk,l
(4.15)
qijkl = 1− pijkl (4.16)
Using the variance we can asses the probability of the measured difference to
belong to this distribution:
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P (x ∈ G(0, V ar(x))) = 1− erf( x√
2V ar(x)
) (4.17)
erf(y) =
2√
pi
∫ y
0
e−t
2
dt (4.18)
4.1.6 Significance of γ
γ is estimated using proportions as in Eq. 4.10. When the interaction between
M and F does not affect T, γ will be approximately normally distributed with
mean zero. Variance of this distribution is estimated in Eq. 4.19.
V ar(γ) = p′q′(
1
n0,0
+
1
n0,1
+
1
n1,0
+
1
n1,1
) (4.19)
p′ =
f0,0,1 + f0,1,1 + f1,0,1 + f1,1,1
n0,0 + n0,1 + n1,0 + n1,1
(4.20)
q′ = 1− p′ (4.21)
We use Eq. 4.17 for assessing the probability of a measured γ to belong to
this normal distribution around zero.
4.1.7 Category of Action
Using αˆf , GEM classifies unmodulated F activity into three classes: activator,
inhibitor, and inactive. Similarly, by comparing αˆ and βˆ coefficients, modulators
are classified into three classes – they can enhance, attenuate, or invert the activity
of the transcription factor. There are 6 possible categories that would have a high
γ. These cases and their interpretations are listed in Table 4.1, Table 4.2, and in
Figure 4.3.
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Figure 4.3: Classifying modulators using proportion differences: a) A triplet
can be represented as a vector 〈(αf , αm), (βf , βm)〉. The size of the vector is
proportional to γ. b) An example of logical-or case. c) An example of too
small γ. Most of the triplets fall into one of these categories and are filtered out
by GEM. 1-6) Representative vectors for each category of action in Tables 4.1
and 4.2, drawn assuming αm = 0.
Modulation Category Explanation
Attenuates Inhibition F, alone, inhibits T – M attenuates F activity.
Enhances Inhibition Modulated F inhibits T.
Inverts Inhibition F, alone, inhibits T – M inverts F activity.
Inverts Activation F, alone, activates T – M inverts F activity.
Enhances Activation Modulated F activates T.
Attenuates Activation F, alone, activates T – M attenuates F activity.
Table 4.1: Interpretation of the categories of modulation.
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Modulation Category γ αf βf βm αf + βm
Attenuates Inhibition + -
Enhances Inhibition - - - -
Inverts Inhibition + - + + +
Inverts Activation - + - - -
Enhances Activation + + + +
Attenuates Activation - +
Table 4.2: Inequality constraints that the category of modulation should satisfy.
“+” and “−” signs in the columns indicate significantly positive and negative
values, respectively. Note that this categorization is formulated for triplets for
which the null hypotheses in Eq. 4.11 were also rejected.
4.2 Results and Discussion
4.2.1 Inferring Modulators of the Androgen Receptor
Androgen Receptor (AR) is critical to the development and maintainance of male
sexual phenotype and is also implicated as a central component in development
of prostate cancer. Heemers et al. provide an extensive list of AR modulators
and targets [40]. In the AR literature, modulators are often classified as co-
activators or co-repressors. However, the semantics of this binary classification
can be ambiguous; for example, “Is a modulator that attenuates the inhibitory
action of a transcription factor a co-activator or co-repressor?” Another implicit
assumption is that most modulators are unimodal; that is, they have a single type
of effect which is either a co-activator or a co-inhibitor for all targets. Heemers et
al. list only 12 out of 192 modulators as bimodal. Since for most modulators only
a few targets are examined in the literature, we expect to have an observation
bias towards unimodality. The extent of this bias, however, is not obvious. To
answer these questions, and gain insight to the AR biology, we have applied GEM
to infer modulators of AR.
For this experiment, we used the expression dataset provided by Expression
Project for Oncology (expO), which contains 2158 profiles from various cancer
tissue samples. Target genes were compiled by combining 40 known AR targets in
Heemers et al. and 30 AR targets listed in TRED [45]. 134 proteins were listed
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Figure 4.4: Target genes of the Androgen Receptor detected to be modulated by
CAV1. KLK3, also known as PSA, is upregulated as well as 4 other important
tumor growth related genes.
in HPRD [50] as interactors of AR forming the modulator candidate set. We
removed genes that are both modulators and targets of AR as well as those that
lacked adequate variability in the expression profiles. We used GEM to detect
which of these 134 proteins modulate AR and compared our results with the list
provided in Heemers et al.
For each modulator, GEM predicts its targets and its category of action. For
example, Figure 4.4 lists the inferred target genes of CAV1 modulation. CAV1
was previously shown to positively regulate AR activity [55] and was associated
with prostate cancer and aggressive PSA (KLK3) recurrence. We observe that
expression levels of all 8 predicted targets were increased in response to CAV1,
including PSA. Four of the eight genes have various growth promoting func-
tions including fatty acid metabolism (ACACB), ketogenesis (HMGCS2), and
angiogenesis (AVP and VEGFA). CASP2 and NKX3-1 have, however, tumor
suppressor functions and are also upregulated by CAV1. These results show a
complicated picture of modulation by CAV1 but are in agreement with previous
studies that show both anti-tumor and metastatic functions for CAV1 [33].
CAV1 fits in nicely with the co-activator classification in the review by
Heemers et al. Most targets of CAV1 fall into “Enhances Upregulation” class and
inverting or even attenuating downregulation can be classified as co-activating.
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Following from this observation, we looked at whether the results inferred by
GEM agree with the review for the other modulators.
Using a 1% false discovery rate, we identified 47 modulators, covering 33 of the
192 modulators listed in Heemers et al. The 25 modulators with the most targets
detected by GEM are listed in Figure 4.5 along with their classification in Heemers
et al. Since we are limiting ourselves to direct modulators, and have a very
conservative false discovery rate, this is a quite good recall. On the other hand
we have predicted 14 modulators that were not listed in the review, including two
master regulators of AR – EGFR and RUNX1. When we searched the literature
for unlisted modulators with the most targets (EGFR, RUNX1, CDC2, CASP1,
and MED1), we were able to find supporting evidence for modulation. Recchia et
al. demonstrated the cross-talk between EGFR and AR pathways by investigating
their effect on CD1 expression [66]. They claim that CD1 expression requires
both EGFR and AR activity. Ning et al. identified modulation of mouse Slp by
RUNX1 via AR [62]. Moilanen et al. show that CDC2 phosphorylates N-terminal
domain of AR, which contains the major transactivation function [61]. Wellington
et al. report cleavage of AR by CASP1 [79]. Wang et al. detect that MED1 plays
an important co-regulatory role in AR-mediated gene expression [77]. These
results show that GEM can complement literature reviews and can identify likely
modulators from protein interactors of transcription factors. More importantly,
GEM can infer target-specific mechanisms for each modulator.
Unlike CAV1, we observe that most modulators are bimodal. Of the top 25,
only JUN and PIAS2 are listed as bimodal in Heemers et al. This difference in
the frequency of bimodal modulators predicted by our method and those found
in the literature supports our supposition that many modulators are classified as
co-activators or co-repressors only because they were tested on a restricted set
of target genes. We also observe that the number of targets for each modulator
varies from 1 to 27. Although the target sets are far from being complete, they
are sufficiently large so we expect the distribution of targets to be representative.
Our results show that there is a spectrum of very specific modulators with a few
targets to few master regulators that affect a majority of AR targets.
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Figure 4.5: Top modulators of Androgen Receptor: each box contains targets
affected by the modulator organized by categories of action and color coded.
If the modulator is listed in the review by Heemers et al., it is noted next to
the name of the modulator. Most modulators have different effects for different
targets and do not necessarily follow the classification in the review.
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As previously mentioned, GEM requires high variance in expression values.
When we do not filter out low variance genes, GEM detects NCOA3 as negative
modulator of AR for most of the target genes. NCOA3 is a generic nuclear
receptor co-activator whose expression does not change much in the cell. Heemers
et al. show that NCOA3 expression is negatively regulated up to 0.5 fold by AR
activation. When the expression of a candidate has low variation, such feedback
loops can lead to false inference. In the same study, the effect of AR activation on
other known modulators including some of the modulators in Figure 4.5 (DDC,
BRCA1, BAG1, CAV1, FLNA, TGFB1I1, and PAK6), were also reported. Since
these genes have very high variance in the dataset, however, these feedback effects
can only account for a small fraction of the observed expression level changes.
We performed a second analysis using GEM on all cancer related transcription
factors and their targets in TRED. Using interactors in HPRD as modulator
candidates we identify 435 M-F pairs in the result. These include 57 TFs and
295 modulators, in which we also observe that the type of modulation depends
on the target gene.
4.2.2 Comparison with MINDy
Both MINDy and GEM infer modulation of transcription factors based on factor-
dependent correlations between modulators and targets. MINDy measures the
differential conditional mutual information (∆CMI) between transcription factor
and target in low and high conditions of modulator (M- and M+). Since mutual
information is a non-negative measure, however, ∆CMI does not differentiate
between the negative and positive modes of modulation. This can be a problem
when the factor has opposite effects under M- and M+, which results in high
mutual information in both cases, and in turn low ∆CMI. An example of such a
relation is the effect of EGFR on the relation of AR with its target MYLK. GEM
detects that AR inhibits MYLK in EGFR- and activates MYLK in EGFR+. 10%
of GEM result triplets with AR have non-significant ∆CMI and would not been
able to be detected by MINDy.
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MINDy treats all signaling proteins as modulator candidates, whereas we
propose a much more conservative approach – we use only known interacting
proteins. Using known protein interactors has the advantage of producing hy-
potheses about direct interactions that are immediately testable. There are com-
binatorially many indirect modulators and to test them, one has to supply the
intermediary molecules to the system. This makes indirect modulators harder to
test, especially in vitro. Also, dependency between M and F activity on T can
be a result of non-causal relations – if any of the M, F, and T genes were replaced
with a highly correlated substitute, there would still be a non-linear dependency.
When we use a priori interactions to construct our triplets, a substantial amount
of indirect and non-causative cases are filtered out. As a tradeoff our method loses
some coverage due to missing or incorrect information in the source databases.
Similar to γ, ∆CMI would also detect a logical-or relation between M and
F. In the case of AR, one third of our result triplets were classified as logical-or
and filtered out. Unlike our approach, MINDy would not differentiate logical-or
from modulation. These relationships can be meaningful in other contexts, such
as genetic interactions. They, however, do not fit into the biological description
of modulation, where the modulator affects the target through the factor. We
believe that there is a value in basing the method on a biological model and fine
tuning assumptions and restrictions based on it, so that the biological interpre-
tation of the results are not ambiguous and they are more testable. To support
other biological models (e.g. genetic interactions) we are developing a customiz-
able GEM service where the user can select different a priori data and filtering
options.
Chapter 5
Tools
Most methods developed as part of this thesis have been put into practice within
software tools. In the remainder of this chapter, we discuss two such tools.
5.1 PATIKAmad
There are many microarray specific statistical tools that normalize and cluster
the data, and provide a variety of visualization options using tables and plots.
Similarly, many pathway databases and tools for creating, storing, querying and
analyzing biological networks exist [7]. But, there are only a few tools that bring
both worlds together. One such tool is GenMAPP [68], which provides static
pathway diagrams and the ability to map color coded expression values on top of
entities in the diagram. MAPPFinder is a tool for finding overrepresented Gene
Ontology (GO) terms in a microarray experiment, and for searching GenMAPP
pathways for the ones that have genes related with these overrepresented GO
terms. However, GenMAPP lacks an integrated database, thus it is incapable
of producing dynamic pathways related with experiments. Cytoscape [51] has
a plugin that loads tab-delimited array data, and performs several statistical
analyses. These values can be visualized on Cytoscape pathways via color coding.
Reactome [59] database shows an overview map of the reactions in the database,
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which is laid out according to the module that the reaction belongs to. They
support loading of microarray values and show them on an overview graph by
color coding, so that users have an idea about the affected module. None of these
tools are, however, capable of connecting microarray data with graph-theoretic
queries or any other advanced graph analysis operations.
We have built a microarray data integration component, called PATIKAmad [3],
within PATIKAweb [28], which is a Web interface to the PATIKA database for
querying, visualizing, and analyzing biological networks. Its ontology supports
pathway graphs at two levels: bioentity level and mechanistic level. Bioentity-
level graphs contain less detailed information, such as protein-protein interac-
tions or transcriptional regulations between biological entities. Mechanistic-level
graphs have state information (e.g. different phosphorylated states) and com-
partment of molecules. This level models reactions with its inputs, outputs, and
effectors.
About graphs at the bioentity level or other levels of similar detail, there
is a small body of literature regarding microarray data integration and co-
analysis [20]. The common goal in almost all these works is to detect regions
or pathways where significant microarray data is somehow “dense”. This ap-
proach makes sense when the mechanism of interactions is not clear in the graph.
However, in the case of mechanistic graphs, interesting paths do not necessarily
have to be rich in microarray annotation. Many reactions are post-translational
events and can be part of a differentially active network without any change of ex-
pression in their actors. Expression changes may be linked through paths, whose
activity change is independent from expressions. In PATIKAmad, we supply a
facility to query for paths between significant nodes (according to users’ signif-
icance criteria) in an integrated pathway knowledgebase, in order to compile a
“graph of interest”.
PATIKAmad accepts tab-delimited microarray data files containing data val-
ues, and external database references. Such files are available from well known
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public microarray databases such as Gene Expression Omnibus, Stanford Mi-
croarray Database, and ArrayExpress. Supported external references are Gen-
Bank, Unigene, Entrez Gene, HUGO Gene Symbol, SWISSPROT, OMIM, Entrez
RefSeq Protein ID, and Entrez RefSeq Transcript ID. During the processing of
tab-delimited files, rows of the array are matched to the objects in the PATIKA
database, and a “.pmad” (PATIKA microarray data format) file is created for
later use in PATIKAmad. Alternatively, one may load their local model, for
instance in BioPAX [25] format, containing external references. Then, microar-
ray data with compatible external references may be loaded and mapped to this
model, facilitating one to work on their proprietary data independent of PATIKA
database.
After loading a set of experiments specified in a “.pmad” file, the user may
set an experiment of interest, or choose to average a group of experiments, or
compare log-2 ratios of two groups. These settings are managed using the Data
Management dialog. This selection determines the value to be used for each row,
directly affecting visualization and querying events. Expression values, calculated
from current experiments of interest, are visualized on the graph through node
coloring and labeling. Visualization options can be modified using the Visual
Settings dialog. Besides the default red/green coloring, the user may customize
coloring by assigning colors to values. Values in between are shown with colors in
between. Rows of the loaded experiment may be visualized in the Values Table,
which also provides an interface for querying the PATIKA database associated
with the selected rows (Figure 5.1). The rows displayed may be filtered by key-
words, which partially exist in external references. Selected rows may be used
for retrieving related PATIKA objects from the database, or for running neigh-
borhood or graph-of-interest queries using related nodes as seed in the database.
These queries may run on either bioentity or mechanistic levels.
An experiment-scale graph-of-interest query using the Graph-of-Interest dia-
log is also supported. This dialog displays the user’s significance criteria for the
rows, length of search path, and type of graph, on which to execute the query.
This query maps significant rows to significant nodes and searches paths between
significant nodes. All paths not longer than the search length are included in the
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Figure 5.1: Part of the Values Table, where experiment rows are filtered with
string “tnfrsf10” in ascending order, according to the log-ratio values. Any num-
ber of rows may be selected and used for executing neighborhood or graph-of-
interest queries.
resulting graph of interest.
5.1.1 Clustering
Clustering is one of the most popular microarray data analysis methods. The aim
here is to group similarly behaving genes, thus to have an idea about modules
and genes whose function is not clear. PATIKAmad supports k-means and hier-
archical clustering of the loaded experiments. Users have the option for scale
normalization, standard normalization, and filtering out a certain percentage
of genes that show low variance. Clustering results can be saved in a “.pcaf”
(PATIKA cluster analysis file) file for later use. Clusters in loaded clustering re-
sults are visualized on pathways using compound graphs or by highlighting nodes
(Figure 5.2).
5.2 ChiBE
Computational biologists have advanced pathway knowledge representation, cre-
ated standards and formats [25, 44, 47, 46, 59, 23], and built more than 300
pathway and interaction databases [7] in recent years. However, current bioinfor-
matics infrastructure is still lacking in software tools for visualizing and analyzing
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Figure 5.2: Part of a MAP Kinase pathway where two clusters are shown using
compound nodes. Loaded microarray values are shown with labels and colors on
nodes.
CHAPTER 5. TOOLS 64
pathways. A main obstacle in this direction has been the fragmented, incomplete,
and incompatible nature of pathway knowledge, making representation and inte-
gration of pathways extremely difficult.
A number of interesting pathway visualization tools [51, 36, 43, 30, 82] have
been developed over the past decade, with diverse analysis focus, from analyz-
ing gene expression profiles to effective database querying, to discovering graph-
theoretic properties in biological networks. Such tools can benefit substantially
from standardization of knowledge representation, pathway-specific layout algo-
rithms, and representation of compound graphs.
5.2.1 Knowledge Representation
BioPAX has made great progress in developing a standard exchange format for
biological pathway data, as a result of several years of community effort. Path-
way Commons (PC) [63], based on BioPAX, was developed as an integrated
single point of access to publicly available pathway information. PC covers ma-
jor pathway databases and already provides integration at the level of molecular
identifiers. Therefore, the community now has an emerging platform for building
software tools and services without worrying about compatibility and fragmenta-
tion issues.
5.2.2 Pathway Layout
General graph layout algorithms do not address the specific needs and established
conventions of pathway graphs. So far, work on pathway layout algorithms [48,
8, 72, 78, 38] has primarily focused on biochemical pathways. Thus, the need for
layout of complex pathways, such as signal transduction, remains to be addressed.
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Tool Layout Compound
Support
Compartment
Visualization
Experiment
Data Visu-
alization
Open
Source
Plugin
Sup-
port
Cytoscape yFiles, Cy-
toscape and
JGraph
layouts
No No Yes Yes Yes
BiNoM Uses Cy-
toscape
layouts
No No N/A Yes N/A
VisAnt Circular
and spring
embedder
Yes No Yes Yes No
PathCase Hierarchical No No No No No
ChiBE CoSE (com-
pound spring
embedder)
layout
Yes Yes Yes Yes No
Table 5.1: Comparison of ChiBE and 4 other tools that support BioPAX vi-
sualization. Tools are compared in the aspects of automated layout support,
compound graph support, compartment visualization and experiment data visu-
alization.
5.2.3 Compound Graphs
ChiBE [5] is an open source visualization tool, which for the first time, brings
together compound graph based BioPAX visualization, seamless Pathway Com-
mons access, pathway specific layout, and strong visualization and data analysis
capabilities. Table 5.1 compares ChiBE with similar visualization tools.
Chapter 6
Conclusion
ChiBE ([5]) is a standalone pathway editor that we developed for working with
BioPAX pathways. It uses Paxtools for reading, manipulating and saving BioPAX
files, and for querying Pathways Commons database. ChiBE draws easy-to-
understand views of BioPAX when the graph is not very large. These views
are similar to SBGN process description language and are generated per path-
way. Most interesting part of ChiBE is its ability to generate small size pathways
out of cluttered files according to user’s point of interest. We realize this by pro-
viding a local querying mechanism, enabling to search for neighborhoods, paths
between molecules, or common upstream or downstream of molecules. We aim to
enrich editing and querying support in ChiBE, provide support for the recently
released BioPAX Level 3 ontology and format, and for the graphical notation
standard SBGN.
Pathway databases collect interactions and reactions in the cell, which were
discovered in different laboratories with different experimental settings. How-
ever, one often wants to restrict the network to a specific cellular context, such
as a tissue with a disease. Expression profiles provide a clue about the active
part of the network by showing expression levels of genes. PATIKAmad ([3])
integrates expression data to networks. It is not an independent software but
a concept that we implemented as a component in both PATIKAweb [28] and
ChiBE. Its function includes reading the expression data and showing expression
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values on related proteins in the network. Alternatively, one can compare two
microarray data and visualize the fold change of expression values. We defined
the term “causative path”, which infers the causes of dependency between expres-
sion value changes through the network. When causative paths are searched and
integrated, PATIKAmad can produce a candidate “network of change” based on
the compared profiles.
One drawback of causative path analysis is that the last step of the path
must be a gene regulation, and gene regulations are poorly covered in pathway
databases. However, many transcription factors are known or predicted along
with their target genes and binding sites in the promoter. We developed a new
method, GEM ([4]), for identification and characterization of modulators of tran-
scription factors (TF). GEM tests if the known binding proteins of TFs has
modulator activity using large number of expression data. It is based on the as-
sumption that gene expressions are correlated with their protein activity, and it
tests if the correlation between modulator and target gene expression depends on
the TF expression. We select modulator candidates among interacting proteins
of TFs to eliminate indirect relations and non-causative correlations. GEM also
identifies the specific mode of action of the modulator on a target.
We have observed that most modulators affect multiple targets and are bi-
modal – they do not have a single mode of action but can act as an enhancer or
attenuator based on the target. The co-activator and co-inhibitor classifications
in the literature reflect a very simplified version of gene regulation as they gen-
eralize the effect of a modulator for a single gene or binding site to all targets.
GEM provides a much larger scope for picking up likely targets and inferring
modulator-target relationships.
Ideally, the regulation at each promoter should be modeled including all major
actors at the site, considering a modulation affects the collective activity of actors
instead of just a single TF. GEM can be extended to model the control at each
promoter. This model would be a basis for predicting effects of upstream events
to gene expressions.
Transcription factors and their modulators are potential drug targets since
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their activity affect expression of target genes whose activity is related to diseases
such as cancer. Here, the idea is to detect the malfunctioning part of the network
and repair or disable it by modifying the control at the upstream. This would
be a straightforward operation if upstream events were composed of linear paths.
However, signaling paths are interlinked, and TFs and modulators affect multiple
target genes that function in diverse mechanisms. For instance, GEM infers that
CAV1 modulates AR on at least 8 target genes, some of which have metastatic
activity while some of other have tumor suppressor activity.
In drug discovery research, one big problem is to find manipulation points that
will affect the targeted downstream mechanism while causing minimal side effects
in healthy cells. This can be achieved by exploiting the robustness of cellular
networks. For instance, one can predict that removal of a modulator will not make
drastic effect while other similarly functioning modulators are abundantly present.
In this direction, we can search for manipulation points whose undesired effects
are mostly through robust control points. Note that robustness here depends on
the specific set of genes expressed, varying in each individual and tissue type.
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Appendix A
Features of ChiBE
ChiBE accepts data in BioPAX Level 2 format. Section 3.2 and Table A.1 sum-
marizes how BioPAX models are interpreted by ChiBE. We call the entire set
of biological information loaded from a BioPAX file a pathway model. As de-
fined by BioPAX, a pathway is a set or series of interactions, often forming a
network, which biologists have assembled for organizational, historic, biophysical
or other reasons. We use pathways to determine the boundaries of a coherent
view. Each loaded pathway is displayed in a separate canvas, organized with tabs
(Figure A.1). A pathway model may be expanded by merging it with another
BioPAX file or PC query.
A pathway view is composed of pathway objects and their interactions. Com-
pound nodes are exclusively used to represent molecular complexes and cellular
compartments (Figure A.1). Our notation is similar to that of PATIKA [23].
ChiBE has context-sensitive pop-up menus associated with pathway objects, pro-
viding fast access to popular operations for the associated pathway object. All
kinds of nodes and edges in a pathway view have distinct properties and UIs.
These properties can be changed by using inspectors for each pathway object.
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Table A.1: BioPAX elements and their corresponding visual elements in ChiBE.
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Figure A.1: ChiBE views are organized in canvasses, each displaying one or more
BioPAX pathways.
A.1 Viewing and Editing Pathways
The user has various mechanisms for navigating and editing the topology as
well as the geometry of pathway views. These mechanisms range from standard
zoom/scroll and highlight operations to modifying the UI associated with each
pathway object and to automatic layout of the pathway view.
A.2 Pathway Operations
Any subset of available pathways in a model may be displayed as a separate view,
and may be saved as an image or printed. Each subset may then be modified
as desired. Also, new pathway views may be created by duplicating, cropping or
capturing a neighborhood of a view.
A.3 Querying Pathway Commons
PC is a convenient point of access to biological pathway information collected
from public pathway databases, which one can browse or search. ChiBE provides
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Figure A.2: Dialog in which a paths-of-interest query is configured. User searchs
paths from CALM1 to CREB1 with a length limit of shortest + 2.
a graphical user interface to search this knowledge base to find pathways that
contain a specified molecule (using its UniProt or Entrez Gene ID), and present
the results in a visual form. The resulting view may contain either the whole
pathway or only the immediate neighborhood of the specified molecule in all the
pathways in which it appears.
A.4 Querying Local Pathway
ChiBE provides a local querying mechanism which helps the user to work on
large models. User can perform neighborhood, paths-of-interest (PoI), graph-of-
interest (GoI) and common-stream queries that we defined in Section 3.4. Fig-
ure A.2 shows the dialog that user specify parameters of a local PoI query, which
looks for paths from CALM1 to CREB1 with a distance limit of shortest path
length plus two. When we run this query on the “NGF Processing” pathway
from Pathway Commons database, we get the result graph in Figure A.3.
A.5 SIF Operations
SIF (Simple Interaction Format) is a format introduced by Cytoscape [51] for
describing interactions in a biological network. ChiBE can reduce BioPAX path-
ways to SIF using a customizable set of rules to obtain a simpler view. Pathways
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Figure A.3: Result of the paths-of-interest query in Figure A.2, performed on the
“NGF Processing” pathway from Pathway Commons database.
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can also be saved in SIF.
A.6 Visualizing High-Throughput Data
Multiple types of high-throughput data, such as gene expression or proteomics
profiles, copy number variation, and mutation data, can be loaded into ChiBE,
and overlaid onto pathway views using color coding or displayed in tables that
can be searched and filtered.
A.7 Availability and Components
ChiBE is a free (EPL v1.0) Java application that runs on Windows, Mac OS,
and Linux. It was built using Chisio 1.0 [16] and Eclipse GEF 3.1 [37] for graph
visualization, Paxtools [64] for accessing and manipulating BioPAX files, and
PATIKAmad [3] for high-throughput data visualization.
